1-15 of 15
Rong TAO
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Linperlisib in Combination with CHOP for Newly-Diagnosed Peripheral T-Cell Lymphoma: Preliminary Results from the Phase 1b/2 Linch Study

Qingqing Cai, Yi Xia, Huiqiang Huang, Ying Zhao, Fan Yang, Wenning Xu, Hongyan Tong, Chunmei Yang, Xiaojie Fang, Man Nie, Yu Fang, Gao Yan, Xuanye Zhang, Rong Tao, Xiuhua Sun, Xueyi Pan, Tao Wu, Yuchen Zhang, Jun Cai
Journal: Blood
Blood (2024) 144 (Supplement 1): 6407.
https://doi.org/10.1182/blood-2024-206564
Published: 2024
Journal Articles

SKYGLO: A Global Phase III Randomized Study Evaluating Glofitamab Plus Polatuzumab Vedotin + Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone (Pola-R-CHP) Versus Pola-R-CHP in Previously Untreated Patients with Large B-Cell Lymphoma (LBCL)

Ranjana H. Advani, Michael J. Dickinson, Christopher P. Fox, Brad Kahl, Alex F. Herrera, Georg Lenz, Yuqin Song, Rong Tao, Qingqing Cai, Tae Min Kim, Michelle Doral, Derrick Kaufman, Leonardo Roque Pereira, Aurelien Berthier, Franck Morschhauser
Journal: Blood
Blood (2024) 144 (Supplement 1): 1718.1.
https://doi.org/10.1182/blood-2024-194000
Published: 2024
Journal Articles

Combination of Mitoxantrone Hydrochloride Liposome with Tislelizumab in Patients with Relapsed or Refractory NK/T Cell Lymphoma: A Phase Ib/Ⅱ Study

Qingqing Cai, Yi Xia, Liang Wang, Dongfeng Zeng, Hongyan Tong, Huiqiang Huang, Yuerong Shuang, Zhigang Peng, Ying Zhao, Xiaobo Wang, Xiuhua Sun, Yu Yang, Daoguang Chen, Zhenya Hong, Jinni Wang, Jun Cai, Wei Zhang, Rong Tao, Hong Cen, Jianzhen Shen, Yirong Jiang, Yan Gao, Xiaojie Fang, Man Nie, Xuanye Zhang, Bing Bai, Yuchen Zhang, Qihua Zou, Xi Li, Chunmei Yang, Xin Gao, Hao Xu
Journal: Blood
Blood (2024) 144 (Supplement 1): 4450.
https://doi.org/10.1182/blood-2024-209224
Published: 2024
Journal Articles

Optimal Timing and Impact of Allogeneic Peripheral Blood Stem Cell Transplantation in Adult T-Cell Lymphoblastic Lymphoma: Insights from a Large Cohort Multi-Center Real-World Study in Shanghai

Fangfang Yu, Jiahua Niu, Jianmin Yang, Jian Hou, Siguo Hao, Aibin Liang, Hong Xiong, Qi Zhu, Ligen Liu, Jun Shi, Juan Du, Bobin Chen, Rong Wei, Wenli Zhao, Lihua Sun, Yunhua Hou, Rong Tao, Xianmin Song
Journal: Blood
Blood (2024) 144 (Supplement 1): 7818.
https://doi.org/10.1182/blood-2024-199964
Published: 2024
Journal Articles

Clinical Features, Management and Prognostic Factors of Patients with Gastric Mucosa-Associated Lymphoid Tissue Lymphoma

Yizhen Liu, Lingyu Liu, Chuanxu Liu, Wenhao Zhang, Shiyu Jiang, Qunling Zhang, Fangfang Lyu, Xiaojian Liu, Junning Cao, Xuejun Ma, Rong Tao
Journal: Blood
Blood (2024) 144 (Supplement 1): 1653.
https://doi.org/10.1182/blood-2024-202237
Published: 2024
Journal Articles

Selinexor Combined with Tislelizumab in Patients with Relapsed or Refractory Extranodal NK/T-Cell Lymphoma (R/R ENKTL): Preliminary Results of Arm C, from a Multicenter, Single-Arm, Phase I/II Study, Touch

Rong Tao, Chuanxu Liu, Yan Gao, Yang Yu, Zhi Guo, Jun Zhao, Huiqiang Huang
Journal: Blood
Blood (2024) 144 (Supplement 1): 4448.
https://doi.org/10.1182/blood-2024-206554
Published: 2024
Journal Articles

Time to Lymphoma Treatment within 24 Months in Watchful Waiting Follicular Lymphoma Defines Patients at High Risk for Progression: A Multicenter Analysis

Fenghua Gao, Jing Liu, Jiesong Wang, Lihong Liu, Zhiming Li, Yuqin Song, Xudong Zhang, Hui Zhou, Xiuhua Sun, Wei Zhang, Bing Xu, Liping Su, Wen Shujuan, Rong Tao, Ou Bai, Qingyuan Zhang, Liqun Zou, Xianhuo Wang, Huilai Zhang
Journal: Blood
Blood (2023) 142 (Supplement 1): 4417.
https://doi.org/10.1182/blood-2023-174308
Published: 2023
Journal Articles

Anti-PD-1 Antibody Sintilimab in Combination with Anlotinib and Pegaspargase As a Highly Effective Salvage Regimen for the Treatment of Relapsed or Refractory Natural Killer /T-Cell Lymphoma

Rong Tao, Chuanxu Liu, Wenhao Zhang, Yang Zhu, Yujie Ma
Journal: Blood
Blood (2023) 142 (Supplement 1): 1694.
https://doi.org/10.1182/blood-2023-191012
Published: 2023
Journal Articles

Clinical Predictors of Central Nervous System Relapse in Primary Breast Diffuse Large B-Cell Lymphoma

Guang-Liang Chen, Pin Guo, Shiyu Jiang, Juan J. Gu, Qunling Zhang, Yizhen Liu, Junning Cao, Xiaonan Hong, Rong TAO, Fangfang Lv
Journal: Blood
Blood (2022) 140 (Supplement 1): 3790–3791.
https://doi.org/10.1182/blood-2022-156877
Published: 2022
Journal Articles

Preliminary Result of Lenalidomide Combined with R-CHOP(R2-CHOP) in Newly Diagnosed Double-Expressor Diffuse Large B-Cell Lymphoma: A Prospective Phase II Clinical Trial

Yizhen Liu, Qunling Zhang, Fangfang Lv, Xiaojian Liu, Dongmei Ji, Zuguang Xia, Jia Jin, Rong TAO, Wenhao Zhang, Xiaoqiu Li, Shengjian Zhang, Jiachen Wang, Xiaonan Hong, Junning Cao
Journal: Blood
Blood (2022) 140 (Supplement 1): 6627–6628.
https://doi.org/10.1182/blood-2022-158657
Published: 2022
Journal Articles

Two-Year Follow-up of Investigator-Initiated Phase 1 Trials of the Safety and Efficacy of Fully Human Anti-Bcma CAR T Cells (CT053) in Relapsed/Refractory Multiple Myeloma

Siguo Hao, MD PhD, Jie Jin, MD PhD, Songfu Jiang, MD, Zonghai Li, MD PhD, Wenhao Zhang, MD PhD, Min Yang, MD PhD, Kang Yu, MD, Wei Wang, MDPhD, Linjun Chen, MD PhD, Haitao Meng, MD PhD, Mingxia He, MD, Jun Xiao, MD, Rong Tao, MD PhD, Xin Huang, MD PhD, Chongyun Xing, MD, Daijing Yuan, MD, Jianbo Wan, MD PhD, Shasha Wang, MD PhD, Lihui Dai, BS, Hong Ma, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 27–28.
https://doi.org/10.1182/blood-2020-140156
Published: 2020
Journal Articles

Phase 1 Trial of the Safety and Efficacy of Fully Human Anti-Bcma CAR T Cells in Relapsed/Refractory Multiple Myeloma

Jin Jie, MD PhD, Siguo Hao, MD PhD, Songfu Jiang, MD, Zonghai Li, MD PhD, Min Yang, MD PhD, Wenhao Zhang, MD PhD, Kang Yu, MD, Jun Xiao, MD, Haitao Meng, MD PhD, Liyuan Ma, MD PhD, Mingxia He, MD, Wei WANG, MD PhD, Xin Huang, MD PhD, Linjun Chen, MD PhD, Chongyun Xing, MD, Daijing Yuan, MD, Shasha Wang, MD PhD, Rong Tao, MD PhD, Lihui Dai, BS, Hong Ma, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4435.
https://doi.org/10.1182/blood-2019-126104
Published: 2019
Journal Articles

Preliminary Results from a Multicenter, Single-Arm, Phase 2 Study of CS1001, an Anti-Programmed Death-Ligand 1 (PD-L1) Human Monoclonal Antibody (mAb), in Patients (pts) with Relapsed or Refractory Extranodal Natural Killer/T Cell Lymphoma (rr-ENKTL)

Hui-qiang Huang, MD PhD, Rong Tao, MD PhD, Liqun Zou, Hong Cen, MD PhD, Ye Guo, MD PhD, Yunhong Huang, MD PhD, Wenbin Qian, MD PhD, Liling Zhang, MD PhD, Hui Zhou, MD PhD, Yu Yang, MD PhD, Haiyan Yang, Dan Zhu, Teng Fang, PhD, Hangjun Dai, Yueling Wang, Jianxin Yang, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2833.
https://doi.org/10.1182/blood-2019-121865
Published: 2019
Journal Articles

Cyclic ADP-Ribose Increases Human Mesenchymal Stem Cells Proliferation through the Modulation of Spontaneous Ca 2+ Oscillation.

Rong Tao, MBBS, MSc, Chu-Pak Lau, MD, Hon-Cheung Lee, PhD, Gui-Rong Li, PhD
Journal: Blood
Blood (2007) 110 (11): 4061.
https://doi.org/10.1182/blood.V110.11.4061.4061
Published: 2007
Journal Articles

Inositol 1,4,5-Trisphosphate Receptors Mediating Spontaneous Ca 2+ Oscillation Favors Proliferation in Human Mesenchymal Stem Cells from Bone Marrow.

Rong Tao, MBBS, MSc, Chu-Pak Lau, M.D., Gui-Rong Li, PhD
Journal: Blood
Blood (2006) 108 (11): 2572.
https://doi.org/10.1182/blood.V108.11.2572.2572
Published: 2006